CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers—findings from two independent populations

Trends in serum cotinine concentrations among daily cigarette smokers: Data from NHANES 1999–2010

(2013) Ram B. Jain   SCIENCE OF THE TOTAL ENVIRONMENT

Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure

(2012) Gideon St.Helen et al.   ADDICTION

Alaska Native smokers and smokeless tobacco users with slower CYP2A6 activity have lower tobacco consumption, lower tobacco-specific nitrosamine exposure and lower tobacco-specific nitrosamine bioactivation

(2012) Andy Z.X. Zhu et al.   CARCINOGENESIS

Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population

(2012) Mohammad Safiqul Islam et al.   CLINICA CHIMICA ACTA

A Nationwide Analysis of US Racial/Ethnic Disparities in Smoking Behaviors, Smoking Cessation, and Cessation-Related Factors

(2011) Dennis R. Trinidad et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

A Sex-Specific Association between a 15q25 Variant and Upper Aerodigestive Tract Cancers

(2011) D. Chen et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk

(2011) Catherine A. Wassenaar et al.   JNCI-Journal of the National Cancer Institute

Lung Cancer Risk Among Smokers of Menthol Cigarettes

(2011) W. J. Blot et al.   JNCI-Journal of the National Cancer Institute

Racial Differences in the Relationship Between Number of Cigarettes Smoked and Nicotine and Carcinogen Exposure

(2011) N. L. Benowitz et al.   NICOTINE & TOBACCO RESEARCH

Sex differences in lung cancer susceptibility: A review

(2010) Chikako Kiyohara et al.   Gender Medicine

Nicotinic Acetylcholine Receptor Region on Chromosome 15q25 and Lung Cancer Risk Among African Americans: A Case–Control Study

(2010) Christopher I. Amos et al.   JNCI-Journal of the National Cancer Institute

Utility and Relationships of Biomarkers of Smoking in African-American Light Smokers

(2009) M. K. Ho et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

CYP450 polymorphisms as risk factors for early-onset lung cancer: gender-specific differences

(2009) Maria N. Timofeeva et al.   CARCINOGENESIS

Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers

(2009) MK Ho et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Structure, Function, Regulation and Polymorphism of Human Cytochrome P450 2A6

(2009) Yuan Di et al.   CURRENT DRUG METABOLISM

Fast model-based estimation of ancestry in unrelated individuals

(2009) D. H. Alexander et al.   GENOME RESEARCH

Intermittent and light daily smoking across racial/ethnic groups in the United States

(2009) Dennis R. Trinidad et al.   NICOTINE & TOBACCO RESEARCH

Phase I Metabolic Genes and Risk of Lung Cancer: Multiple Polymorphisms and mRNA Expression

(2009) Melissa Rotunno et al.   PLoS One

Body Mass Index and Waist Circumference in Relation to Lung Cancer Risk in the Women's Health Initiative

(2008) G. C. Kabat et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent

(2008) Jill C. Mwenifumbo et al.   HUMAN MUTATION

The CHRNA5-A3 Region on Chromosome 15q24-25.1 Is a Risk Factor Both for Nicotine Dependence and for Lung Cancer

(2008) Margaret R. Spitz et al.   JNCI-Journal of the National Cancer Institute

CYP2A6polymorphisms and risk for tobacco-related cancers

(2008) Ana Rossini et al.   PHARMACOGENOMICS

Comparison of aspects of smoking among the four histological types of lung cancer

(2008) S A Kenfield et al.   TOBACCO CONTROL